Abstract: Chimeric virus-like particles (VLPs) were developed as a candidate for allergen-specific immunotherapy. In this study, hepatitis B core antigen (HBcAg) that genetically fused to Chenopodium album polcalcin (Che a 3)–derived peptide was expressed in E. coli BL21, purified, and VLP formation was evaluated using native agarose gel electrophoresis (NAGE) and transmission electron microscopy (TEM). Chimeric HBc VLPs were characterized in terms of their reactivity to IgE, the induction of blocking IgG and allergen-specific IgE, basophil-activating capacity, and Th1-type immune responses. Results from IgE reactivity and basophil activation test showed that chimeric HBc VLPs lack IgE-binding capacity and basophil degranulation activity. A...
BACKGROUND: Synthetic contiguous overlapping peptides (COPs) may represent an alternative to allerge...
Purpose: Allergen-specific immunotherapy (SIT) requires dozens of subcutaneous injections over 3 to ...
Background Recombinant hypoallergenic allergen derivatives have been used in clinical immunotherapy ...
Abstract: Chimeric virus-like particles (VLPs) were developed as a candidate for allergen-specific i...
Chenopodium album polcalcin (Che a 3) is characterized as a major cause of cross-reactivity inallerg...
Aim To investigate the immunomodulatory potential of a chimera composed of the receptor-binding doma...
Chenopodium album polcalcin (Che a 3) is characterized as a major cause of cross-reactivity inallerg...
Objective(s): New generation of allergy vaccines is capable of promoting the development of protecti...
Allergen immunotherapy (AIT) is the only disease-modifying treatment with evidence for sustained eff...
Immunotherapy for type I allergies is well established and is regarded to be the most efficient trea...
Allergen immunotherapy (AIT) is the only disease-modifying treatment with evidence for sustained eff...
Background: We have constructed and clinically evaluated a hypoallergenic vaccine for grass pollen a...
Allergic responses are strongly associated with Th2-type immune responses, and modulation of the ske...
Immunotherapy for type I allergies is well established and is regarded to be the most efficient trea...
Aim: House dust mite (HDM) allergens are important elicitors of IgE-mediated allergies. This study w...
BACKGROUND: Synthetic contiguous overlapping peptides (COPs) may represent an alternative to allerge...
Purpose: Allergen-specific immunotherapy (SIT) requires dozens of subcutaneous injections over 3 to ...
Background Recombinant hypoallergenic allergen derivatives have been used in clinical immunotherapy ...
Abstract: Chimeric virus-like particles (VLPs) were developed as a candidate for allergen-specific i...
Chenopodium album polcalcin (Che a 3) is characterized as a major cause of cross-reactivity inallerg...
Aim To investigate the immunomodulatory potential of a chimera composed of the receptor-binding doma...
Chenopodium album polcalcin (Che a 3) is characterized as a major cause of cross-reactivity inallerg...
Objective(s): New generation of allergy vaccines is capable of promoting the development of protecti...
Allergen immunotherapy (AIT) is the only disease-modifying treatment with evidence for sustained eff...
Immunotherapy for type I allergies is well established and is regarded to be the most efficient trea...
Allergen immunotherapy (AIT) is the only disease-modifying treatment with evidence for sustained eff...
Background: We have constructed and clinically evaluated a hypoallergenic vaccine for grass pollen a...
Allergic responses are strongly associated with Th2-type immune responses, and modulation of the ske...
Immunotherapy for type I allergies is well established and is regarded to be the most efficient trea...
Aim: House dust mite (HDM) allergens are important elicitors of IgE-mediated allergies. This study w...
BACKGROUND: Synthetic contiguous overlapping peptides (COPs) may represent an alternative to allerge...
Purpose: Allergen-specific immunotherapy (SIT) requires dozens of subcutaneous injections over 3 to ...
Background Recombinant hypoallergenic allergen derivatives have been used in clinical immunotherapy ...